Anlotinib Suppresses Oral Squamous Cell Carcinoma Growth and Metastasis by Targeting the RAS Protein to Inhibit the PI3K/Akt Signalling Pathway

<div>Anlotinib inhibited the proliferation of HSC-3 cells. HSC-3 cells were treated with different concentrations (0, 1, 2, and 4 <i>μ</i>M/L) of anlotinib for 10 days. (a) The effect of anlotinib on proliferation of HSC-3 cells. (b) Inhibition ratio of anlotinib on proliferation of HSC-3 cells. The results are from three independent experiments.</div>

Analytical Cellular Pathology

fig2

Figure 2

Figure 2: Anlotinib Suppresses Oral Squamous Cell Carcinoma Growth and Metastasis by Targeting the RAS Protein to Inhibit the PI3K/Akt Signalling Pathway 

Figure 2 | Anlotinib Suppresses Oral Squamous Cell Carcinoma Growth and Metastasis by Targeting the RAS Protein to Inhibit the PI3K/Akt Signalling Pathway 